Companies: 10,795·Total market cap: $144.5T
Advanced Biomedical Technologies, Inc.

Advanced Biomedical Technologies, Inc.

ABMTOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$50000
P/E Ratio—
52W High$0.0005
52W Low$0.0001
Overview

Advanced Biomedical Technologies, Inc. (ABMT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001385799 · ABMT · OTC · as of Jun 9, 2026

Filing snapshot

162
Total Filings
15-12G
Latest Form
2022-01-27
Most Recent
2010
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001385799 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2021-01-29
Fiscal Year End
Jan 29, 2021
Accession No.
0001493152-21-002055
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001385799 · Accession 0001493152-21-002055

Latest Key Filings

10-QQuarterly Report
Quarterly Report
2021-09-13
View 10-Q on SEC
8-KCurrent Report
Current Report
2020-03-13Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2022-01-27
View
10-QQuarterly Report
Quarterly Report
2021-09-13
View
10-QQuarterly Report
Quarterly Report
2021-06-21
View
NT 10-QNT 10-Q
NT 10-Q
2021-06-14
View
10-QQuarterly Report
Quarterly Report
2021-03-22
View
NT 10-QNT 10-Q
NT 10-Q
2021-03-17
View
10-KAnnual Report
Annual Report
2021-01-29
View
10-QQuarterly Report
Quarterly Report
2020-09-21
View
NT 10-QNT 10-Q
NT 10-Q
2020-09-14
View
10-Q/AQuarterly Report (Amended)
Quarterly Report (Amended)
2020-08-20
View
10-QQuarterly Report
Quarterly Report
2020-06-22
View
NT 10-QNT 10-Q
NT 10-Q
2020-06-15
View
UPLOADUPLOAD
UPLOAD
2020-05-20
View
CORRESPCORRESP
CORRESP
2020-05-05
View
10-QQuarterly Report
Quarterly Report
2020-04-30
View
Showing 1–15 of 151 filingsForm 4 / 144 hidden· 162 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001385799  |  Exchange: OTC · Healthcare

Advanced Biomedical Technologies, Inc. (OTC: ABMT) has submitted 162 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2010. As a Healthcare sector company with CIK 0001385799, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Advanced Biomedical Technologies, Inc.'s most comprehensive regulatory disclosure. The most recent Advanced Biomedical Technologies, Inc. 10-K was filed on 2021-01-29 for fiscal year ending 2021. Historical ABMT 10-K annual reports are available from 2007 through 2021.

Investors researching Advanced Biomedical Technologies, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
MDXL SEC Filings →NUGS SEC Filings →PTLF SEC Filings →HSMD SEC Filings →VRAYQ SEC Filings →WCUI SEC Filings →ECGI SEC Filings →ASFX SEC Filings →
→ ABMT Financials→ ABMT Earnings→ ABMT Insider Trades

Frequently Asked Questions

ABMT SEC Filings · 8 questions

Advanced Biomedical Technologies, Inc. (ABMT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 162 filings and access original documents at no cost. Advanced Biomedical Technologies, Inc.'s CIK is 0001385799.

ABMT SEC filingsAdvanced Biomedical Technologies, Inc. SEC documentsfind ABMT 10-K